Industry News

Teva Announces First Approval and Launch of Generic Lovaza� Capsules in the United States
Teva Announces First Approval and Launch of Generic Lovaza Capsules in the United States
Stemline Therapeutics Announces FDA Acceptance of IND for SL-701, a Synthetic Multi-Peptide Vaccine Targeting Glioma Brain Tumors
Regionwide bioscience job fair on Thursday
Sun Pharma to pay $3.2 billion for Ranbaxy, will be world No. 5 [India Business]
Wartrol: The 100% Natural & FDA Approved Genital Warts Removal Treatment Product Available in the Market with One Extra Bottle Offer
Now, heart patients can get new aortic valve without open-heart surgery
Wartrol: The 100% Natural & FDA Approved Genital Warts Removal Treatment Product Available in the Market with One Extra Bottle Offer
Biocon rejects Novartis patent infringement charge
Biocon rejects Novartis patent infringement charge
Teva Announces First Approval and Launch of Generic Lovaza� Capsules in the United States
United Kingdom : Hikma announces successful resolution to US FDA warning letter at Eatontown facility
Meda turns down approach from Mylan
Now, heart patients can get new aortic valve without open-heart surgery
Via Surgical Ltd. Receives FDA Clearance to Commercialize FasTouch(TM), the First Suture-Like Mesh Fixation System for Hernia Repair
Via Surgical Ltd. Receives FDA Clearance to Commercialize FasTouch(TM), the First Suture-Like Mesh Fixation System for Hernia Repair
FDA Advisory Committee OKs Cubist's SIVEXTRO as Treatment for Serious Skin Infections
United Kingdom : Hikma announces successful resolution to US FDA warning letter at Eatontown facility
United Kingdom : Hikma announces successful resolution to US FDA warning letter at Eatontown facility
FDA approves easy-to-use heroin overdose antidote
Baxter International to acquire Chapel Hill biotech company for $70 million
Orphan drugs market offers big financial incentives
Meda turns down approach from Mylan
Baxter International to acquire Chapel Hill biotech company for $70 million
Orphan drugs market offers big financial incentives